CDKN2A/p16 Loss Implicates CDK4 as a Therapeutic Target in Imatinib-Resistant Dermatofibrosarcoma Protuberans

标题
CDKN2A/p16 Loss Implicates CDK4 as a Therapeutic Target in Imatinib-Resistant Dermatofibrosarcoma Protuberans
作者
关键词
-
出版物
MOLECULAR CANCER THERAPEUTICS
Volume 14, Issue 6, Pages 1346-1353
出版商
American Association for Cancer Research (AACR)
发表日期
2015-04-08
DOI
10.1158/1535-7163.mct-14-0793

向作者/读者发起求助以获取更多资源

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started